Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

Filatenkov A, Baker J, Mueller AM, Kenkel J, Ahn GO, Dutt S, Zhang N, Kohrt H, Jensen K, Dejbakhsh-Jones S, Shizuru JA, Negrin RN, Engleman EG, Strober S.

Clin Cancer Res. 2015 Aug 15;21(16):3727-39. doi: 10.1158/1078-0432.CCR-14-2824. Epub 2015 Apr 13.

2.

Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation.

Scandling JD, Busque S, Shizuru JA, Lowsky R, Hoppe R, Dejbakhsh-Jones S, Jensen K, Shori A, Strober JA, Lavori P, Turnbull BB, Engleman EG, Strober S.

Am J Transplant. 2015 Mar;15(3):695-704. doi: 10.1111/ajt.13091.

3.

Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.

Filatenkov A, Baker J, Müller AM, Ahn GO, Kohrt H, Dutt S, Jensen K, Dejbakhsh-Jones S, Negrin RS, Shizuru JA, Engleman EG, Strober S.

Radiat Res. 2014 Aug;182(2):163-9. doi: 10.1667/RR13471.1. Epub 2014 Jul 3.

4.

Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.

Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Sarwal M, Millan MT, Shizuru JA, Lowsky R, Engleman EG, Strober S.

Am J Transplant. 2012 May;12(5):1133-45. doi: 10.1111/j.1600-6143.2012.03992.x. Epub 2012 Mar 8.

5.

Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation.

Filatenkov A, Müller AM, Tseng WW, Dejbakhsh-Jones S, Winer D, Luong R, Shizuru JA, Engleman EG, Strober S.

J Immunol. 2009 Dec 1;183(11):7196-203. doi: 10.4049/jimmunol.0900159. Epub 2009 Nov 4.

6.

Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA, Hoppe RT, Lowsky R, Engleman EG, Strober S.

N Engl J Med. 2008 Jan 24;358(4):362-8. doi: 10.1056/NEJMoa074191.

7.

Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation.

Pillai A, Teo P, George T, Mukhopadhyay A, Dejbakhsh-Jones S, Strober S.

Bone Marrow Transplant. 2007 Sep;40(5):487-97. Epub 2007 Jul 2.

PMID:
17603512
8.
9.

Protective conditioning for acute graft-versus-host disease.

Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, Bloch DA, Blume KG, Negrin RS, Strober S.

N Engl J Med. 2005 Sep 29;353(13):1321-31. Erratum in: N Engl J Med. 2006 Feb 23;354(8):884.

10.

Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus.

García-Ojeda ME, Dejbakhsh-Jones S, Chatterjea-Matthes D, Mukhopadhyay A, BitMansour A, Weissman IL, Brown JM, Strober S.

J Immunol. 2005 Oct 1;175(7):4363-73.

11.

Early defect prethymic in bone marrow T cell progenitors in athymic nu/nu mice.

Chatterjea-Matthes D, García-Ojeda ME, Dejbakhsh-Jones S, Jerabek L, Manz MG, Weissman IL, Strober S.

J Immunol. 2003 Aug 1;171(3):1207-15.

12.

Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion.

Higuchi M, Zeng D, Shizuru J, Gworek J, Dejbakhsh-Jones S, Taniguchi M, Strober S.

J Immunol. 2002 Nov 15;169(10):5564-70.

13.

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S.

Transplantation. 2002 May 15;73(9):1386-91.

PMID:
12023614
14.

Clonable progenitors committed to the T lymphocyte lineage in the mouse bone marrow; use of an extrathymic pathway.

Dejbakhsh-Jones S, Garcia-Ojeda ME, Chatterjea-Matthes D, Zeng D, Strober S.

Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7455-60. Epub 2001 Jun 5.

15.

Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow.

Dejbakhsh-Jones S, Strober S.

Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14493-8.

16.

Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.

Zeng D, Gazit G, Dejbakhsh-Jones S, Balk SP, Snapper S, Taniguchi M, Strober S.

J Immunol. 1999 Nov 15;163(10):5338-45.

17.

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, García-Ojeda M, Sibley R, Strober S.

J Exp Med. 1999 Apr 5;189(7):1073-81.

18.

An alternate pathway for T cell development supported by the bone marrow microenvironment: recapitulation of thymic maturation.

García-Ojeda ME, Dejbakhsh-Jones S, Weissman IL, Strober S.

J Exp Med. 1998 Jun 1;187(11):1813-23.

19.

Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines.

Zeng D, Dick M, Cheng L, Amano M, Dejbakhsh-Jones S, Huie P, Sibley R, Strober S.

J Exp Med. 1998 Feb 16;187(4):525-36.

21.

Different patterns of TCR transgene expression in single-positive and double-negative T cells. Evidence for separate pathways of T cell maturation.

Cheng L, Dejbakhsh-Jones S, Liblau R, Zeng D, Strober S.

J Immunol. 1996 May 15;156(10):3591-601.

PMID:
8621892
22.

Double negative (CD4-CD8- alpha beta+) T cells which promote tolerance induction and regulate autoimmunity.

Strober S, Cheng L, Zeng D, Palathumpat R, Dejbakhsh-Jones S, Huie P, Sibley R.

Immunol Rev. 1996 Feb;149:217-30. Review. No abstract available.

PMID:
9005216
23.

Extrathymic maturation of alpha beta T cells from hemopoietic stem cells.

Dejbakhsh-Jones S, Jerabek L, Weissman IL, Strober S.

J Immunol. 1995 Oct 1;155(7):3338-44.

PMID:
7561027
24.

The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.

Palathumpat V, Dejbakhsh-Jones S, Strober S.

Transplantation. 1995 Aug 27;60(4):355-61.

PMID:
7652765
25.

Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.

Schriber JR, Dejbakhsh-Jones S, Kusnierz-Glaz CR, Ginzton N, Still B, Negrin RS, Greenberg P, Strober S.

Exp Hematol. 1995 Aug;23(9):1024-9.

PMID:
7543414
26.

Similar rates of production of T and B lymphocytes in the bone marrow.

Dejbakhsh-Jones S, Okazaki H, Strober S.

J Exp Med. 1995 Jun 1;181(6):2201-11.

27.

Homogeneous antigen receptor beta-chain genes in cloned CD4- CD8- alpha beta T suppressor cells.

Schmidt-Wolf IG, Liang O, Dejbakhsh-Jones S, Wang H, Cheng L, Holm B, Bell R, Strober S.

J Immunol. 1993 Nov 15;151(10):5348-53.

PMID:
8228230
28.

T-cell subsets and suppressor cells in human bone marrow.

Schmidt-Wolf IG, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S.

Blood. 1992 Dec 15;80(12):3242-50.

PMID:
1467527
29.

Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.

Palathumpat V, Dejbakhsh-Jones S, Holm B, Strober S.

J Immunol. 1992 Aug 1;149(3):808-17.

PMID:
1386094
30.

Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.

Palathumpat V, Holm B, Dejbakhsh-Jones S, Strober S.

J Immunol. 1992 May 15;148(10):3319-26.

PMID:
1578152
31.

Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity.

Palathumpat V, Dejbakhsh-Jones S, Holm B, Wang H, Liang O, Strober S.

J Immunol. 1992 Jan 15;148(2):373-80.

PMID:
1309556

Supplemental Content

Loading ...
Support Center